Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Details)

v3.22.2.2
Fair Value (Details) - USD ($)
9 Months Ended
Oct. 04, 2019
Oct. 01, 2022
Oct. 02, 2021
Dec. 31, 2021
Jul. 03, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Contingent Consideration Liability Fair Value Adjustment   $ 0 $ 2,200,000    
Diagnosys          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Cash purchase price $ 7,000,000        
Financial liabilities carried at fair value 2,500,000 $ 0   $ 0 $ 0
Potential additional earn-out $ 13,000,000        
Achievement period (in years) 3 years        
Earn-out achievement benchmark $ 72,000,000        
Contingent Consideration Liability Fair Value Adjustment     $ 2,200,000